Advanced Accelerator Applications   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Saint Denis Pouilly France (2002)
Status: Acquired by Novartis (2018)

Organization Overview

First Clinical Trial
2011
NCT01379677
First Marketed Drug
2016
gallium-68-dotatate (netspot)
First NDA Approval
2016
gallium-68-dotatate (netspot)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Advanced Accelerator Applications